11. Clinical Outcomes of Second‐Line Chemotherapy in Patients with Previously Treated Advanced Thymic Carcinoma: A Retrospective Analysis of 191 Patients from the NEJ023 Study. (26th November 2019) Authors: Tateishi, Kazunari; Ko, Ryo; Shukuya, Takehito; Okuma, Yusuke; Watanabe, Satoshi; Kuyama, Shoichi; Murase, Kyoko; Tsukita, Yoko; Ashinuma, Hironori; Nakagawa, Taku; Uematsu, Kazutsugu; Nakao, Mika; Mori, Yoshiaki; Kaira, Kyoichi; Mouri, Atsuto; Miyabayashi, Takao; Sakashita, Hiroyuki; Matsumoto, ... Journal: Oncologist Issue: Volume 25:Number 4(2020) Page Start: e668 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
12. Correlation between S-1 treatment outcome and expression of biomarkers for refractory thymic carcinoma. Issue 1 (December 2016) Authors: Okuma, Yusuke; Hosomi, Yukio; Miyamoto, Shingo; Shibuya, Masahiko; Okamura, Tatsuru; Hishima, Tsunekazu Journal: BMC cancer Issue: Volume 16:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
13. Correlation between S-1 treatment outcome and expression of biomarkers for refractory thymic carcinoma. Issue 1 (December 2016) Authors: Okuma, Yusuke; Hosomi, Yukio; Miyamoto, Shingo; Shibuya, Masahiko; Okamura, Tatsuru; Hishima, Tsunekazu Journal: BMC cancer Issue: Volume 16:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
14. Corrigendum to: Feasibility of next-generation sequencing (Oncomine™ DX Target Test) for the screening of oncogenic mutations in advanced non-small-cell lung cancer patients. (8th June 2021) Authors: Takeyasu, Yuki; Yoshida, Tatsuya; Motoi, Noriko; Teishikata, Takashi; Tanaka, Midori; Matsumoto, Yuji; Shinno, Yuki; Okuma, Yusuke; Goto, Yasushi; Horinouchi, Hidehito; Kakishima, Hiroki; Tsuchida, Takaaki; Yamamoto, Noboru; Ohe, Yuichiro; Yatabe, Yasushi Journal: Japanese journal of clinical oncology Issue: Volume 51:Number 7(2021) Page Start: 1183 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
15. Early change in the clearance of pembrolizumab reflects the survival and therapeutic response: A population pharmacokinetic analysis in real-world non-small cell lung cancer patients. (November 2022) Authors: Ohuchi, Mayu; Yagishita, Shigehiro; Jo, Hitomi; Akagi, Kazumasa; Inaba Higashiyama, Ryoko; Masuda, Ken; Shinno, Yuki; Okuma, Yusuke; Yoshida, Tatsuya; Goto, Yasushi; Horinouchi, Hidehito; Makino, Yoshinori; Yamamoto, Noboru; Ohe, Yuichiro; Hamada, Akinobu Journal: Lung cancer Issue: Volume 173(2022) Page Start: 35 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
16. Eltrombopag olamine for refractory immune-related thrombocytopenia induced by pembrolizumab in a non-small cell lung cancer patient. (August 2020) Authors: Ito, Munehiro; Kanda, Shintaro; Yoshida, Tatsuya; Okuma, Yusuke; Jo, Hitomi; Fukuhara, Suguru; Maeshima, Akiko Miyagi; Ohe, Yuichiro Journal: Lung cancer Issue: Volume 146(2020) Page Start: 362 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
17. Erratum to: Correlation between S-1 treatment outcome and expression of biomarkers for refractory thymic carcinoma. Issue 1 (December 2016) Authors: Okuma, Yusuke; Hosomi, Yukio; Miyamoto, Shingo; Shibuya, Masahiko; Okamura, Tatsuru; Hishima, Tsunekazu Journal: BMC cancer Issue: Volume 16:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
18. Exploration of germline variants responsible for adverse events of crizotinib in anaplastic lymphoma kinase-positive non-small cell lung cancer by target-gene panel sequencing. (February 2019) Authors: Mizugaki, Hidenori; Hamada, Akinobu; Shibata, Tatsuhiro; Hosoda, Fumie; Nakamura, Hiromi; Okuma, Yusuke; Shukuya, Takehito; Umemura, Shigeki; Horiike, Atsushi; Fukui, Tomoya; Kogure, Yoshihito; Daga, Haruko; Urata, Yoshiko; Yamada, Kazuhiko; Saeki, Sho; Fujisaka, Yasuhito; Nakamura, Yukiko; Sato,... Journal: Lung cancer Issue: Volume 128(2019) Page Start: 20 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
19. Feasibility of next-generation sequencing (Oncomine™ DX Target Test) for the screening of oncogenic mutations in advanced non-small-cell lung cancer patients. (21st April 2021) Authors: Takeyasu, Yuki; Yoshida, Tatsuya; Motoi, Noriko; Teishikata, Takashi; Tanaka, Midori; Matsumoto, Yuji; Shinno, Yuki; Okuma, Yusuke; Goto, Yasushi; Horinouchi, Hidehito; Kakishima, Hiroki; Tsuchida, Takaaki; Yamamoto, Noboru; Ohe, Yuichiro; Yatabe, Yasushi Journal: Japanese journal of clinical oncology Issue: Volume 51:Number 7(2021) Page Start: 1114 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
20. Feasibility study of docetaxel plus bevacizumab as first line therapy for elderly patients with advanced non-small-cell lung cancer: Thoracic Oncology Research Group (TORG) 1014. Issue 1 (December 2015) Authors: Takagi, Yusuke; Hosomi, Yukio; Oshita, Fumihiro; Okamoto, Hiroaki; Seki, Nobuhiko; Minato, Koichi; Aono, Hiromi; Yamada, Kouzo; Okuma, Yusuke; Hida, Naoya; Sakamoto, Takahiko; Miura, Yosuke; Yomota, Makiko; Satoh, Akira; Kunitoh, Hideo; Sakamaki, Kentaro; Shibuya, Masahiko; Watanabe, Koshiro Journal: BMC cancer Issue: Volume 15:Issue 1(2015) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗